Regulation of the CYP27B1 5′-flanking region by transforming growth factor-beta in ROS 17/2.8 osteoblast-like cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 103, Issue 3-5, 2007, Pages 322-325

  Turner, Andrew G ^a,b   Dwivedi, Prem P ^b   May, Brian K ^a,b   Morris, Howard A ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b HANSON INSTITUTE   (Australia)

Author keywords

CYP27B1; Osteoblasts; Promoter; TGF beta; Vitamin D

Indexed keywords

CALCITRIOL; LUCIFERASE; PARATHYROID HORMONE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; GENE CONTROL; GENE EXPRESSION; HUMAN; KIDNEY CELL; NONHUMAN; OSTEOBLAST; PLASMID; RAT; REPORTER GENE;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; 5' FLANKING REGION; ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; OSTEOBLASTS; RATS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33947188130     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.12.041     Document Type: Article

References (15)

1. Fraser D.R., and Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature 228 273 (1970) 764-766
2. Turner R.T., et al. In vitro synthesis of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells. Proc. Natl. Acad. Sci. U.S.A. 77 10 (1980) 5720-5724
3. Anderson P.H., May B.K., and Morris H.A. Vitamin D metabolism: new concepts and clinical implications. Clin. Biochem. Rev. 24 (2003) 13-26
4. Gao X.H., et al. Basal and parathyroid hormone induced expression of the human 25-hydroxyvitamin D 1alpha-hydroxylase gene promoter in kidney AOK-B50 cells: role of Sp1, Ets and CCAAT box protein binding sites. Int. J. Biochem. Cell Biol. 34 8 (2002) 921-930
5. Dwivedi P.P., et al. Identification of growth factor independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cancer cells. Endocr. Relat. Cancer 12 2 (2005) 351-365
6. 3 in intact animals. Endocrinology 140 5 (1999) 2224-2231
7. 3. Biochem. Biophys. Res. Commun. 249 1 (1998) 11-16
8. Zoidis E., et al. IGF-I and GH stimulate Phex mRNA expression in lungs and bones and 1,25-dihydroxyvitamin D(3) production in hypophysectomized rats. Eur. J. Endocrinol. 146 1 (2002) 97-105
9. 3 levels. Bone 36 4 (2005) 654-662
10. 3 metabolism by lipopolysaccharide-stimulated normal human macrophages. J. Clin. Endocrinol. Metab. 64 1 (1987) 1-9
11. Adams J.S., et al. Potentiation of the macrophage 25-hydroxyvitamin D-1-hydroxylation reaction by human tuberculous pleural effusion fluid. J. Clin. Endocrinol. Metab. 69 2 (1989) 457-460
12. Reichel H., Koeffler H.P., and Norman A.W. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 320 15 (1989) 980-991
13. 3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis. J. Clin. Endocrinol. Metab. 65 6 (1987) 1201-1209
14. 3 increases transforming growth factor and transforming growth factor receptor type I and II synthesis in human bone cells. Biochem. Biophys. Res. Commun. 239 3 (1997) 734-739
15. 3 and activity on human osteoblast-like cells in short-term cultures. Bone 11 2 (1990) 81-86